China Chemical & Pharmaceutical Co., Ltd. (1701.TW)
- Previous Close
22.10 - Open
22.10 - Bid 21.85 x --
- Ask 21.90 x --
- Day's Range
21.85 - 22.15 - 52 Week Range
21.20 - 28.00 - Volume
346,584 - Avg. Volume
663,044 - Market Cap (intraday)
6.543B - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
20.32 - EPS (TTM)
1.08 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield 0.80 (3.62%)
- Ex-Dividend Date Jul 25, 2023
- 1y Target Est
--
China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs. It also offers nutritional supplements comprising vitamins, liver toning agents, and electrolyte and calorie preparations; antipyretic, analgesic, and anti-inflammatory medicines; digestive drugs, intestinal improvement agents, and antispasmodics; cough suppressants, antihistamines, and asthma treatment agents; BPH drugs for the urinary system; hypnotic, mental stability, and antidepressant drugs; hematology/oncology drugs; and other general preparations. In addition, the company provides over the counter drugs such as vitamins, external skin care products, cold and cough medicines, anti-inflammatory analgesics, and gastrointestinal drugs; and antibacterial and disinfection medicines. Further, it manufactures animal health products, including drugs for pigs and cattle, companion animal products, poultry drugs, and feed supplements; and offers contract manufacturing services. China Chemical & Pharmaceutical Co., Ltd. was founded in 1952 and is headquartered in Taipei, Taiwan.
www.ccpc.com.tw--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 1701.TW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1701.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1701.TW
Valuation Measures
Market Cap
6.59B
Enterprise Value
9.54B
Trailing P/E
20.46
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.77
Price/Book (mrq)
0.89
Enterprise Value/Revenue
1.11
Enterprise Value/EBITDA
12.47
Financial Highlights
Profitability and Income Statement
Profit Margin
3.76%
Return on Assets (ttm)
1.16%
Return on Equity (ttm)
4.34%
Revenue (ttm)
8.57B
Net Income Avi to Common (ttm)
322.29M
Diluted EPS (ttm)
1.08
Balance Sheet and Cash Flow
Total Cash (mrq)
489.22M
Total Debt/Equity (mrq)
46.02%
Levered Free Cash Flow (ttm)
-86.11M
Company Insights: 1701.TW
1701.TW does not have Company Insights